Product Details

Braftovi 75 mg Capsules**

Encorafenib
75 mg
Capsule

ROA

Oral

Applicant Name

Pfizer Specialties Ltd

NRN

A4-100331

Status

Active


Composition

Each hard capsule contains: Encorafenib 75 mg. Excipients: Capsule content - Copovidone (E1208) Poloxamer 188 Cellulose microcrystalline (E460i) Succinic acid (E363) Crospovidone (E1202) Silica colloidal anhydrous (E551) Magnesium stearate (E470b) Capsule shell - Gelatin (E441) Titanium dioxide (E171) Iron oxide red (E172) Iron oxide yellow (E172) Iron oxide black (E172)  

ATC Code

L01EC03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

42's (in polyamide/aluminium/PVC/aluminium/ PET/paper perforated unit dose blisters)  

Product Description

Hard capsule (capsule). Flesh coloured opaque cap and white opaque body, printed with a stylised “A” on the cap and “LGX 75mg” on the body. The length of the capsule is approximately 23 mm

Manufacturer Name

Catalent Pharma Solutions LLC

Manufacturer Country

UNITED STATES OF AMERICA  

Approval Date

2023-01-26  

Expiry Date

2028-01-25